Clinical Trials

 

Andrews–Paulos Research & Education Institute: Clinical Trials

APREI provides the oversight, staff and support for the implementation of clinical studies that keep our physicians on the cutting–edge of medicine.

These studies provide patients the latest technological advancements in pharmaceuticals and medical devices and aid both physicians and patients in making better informed treatment decisions. These studies impact the clinical outcomes for patients as our findings are shared with clinicians throughout the world.

Current Clinical Trials At Andrews–Paulos Research & Education Institute


Name AOSSM–Association of Orthopedics and Sports Medicine Association
Description A national survey of youth baseball pitchers regarding pitching exposure and elbow and shoulder problems
Investigator Juliet M. DeCampos, M.D.
Discipline Orthopaedics & Sports Medicine
Target Disease Youth Baseball Pitchers in the Community and Surrounding Communities

Name AOSSM–Association of Orthopedics and Sports Medicine Association
Description Association among pitching variables, elbow or shoulder injuries, and structural arm differences in youth baseball pitchers seen in the clinic
Investigator Juliet M. DeCampos, M.D.
Discipline Orthopaedics & Sports Medicine
Target Disease Youth Baseball Pitchers in the Community and Surrounding Communities

Name BREG
Description Investigation of the subjective effects of the use of two non–invasive modalities in the treatment of symptomatic medial compartment OA of the knee
Investigator Roger V. Ostrander, M.D.
Discipline Orthopaedics
Target Disease  

Name CAIS
Description A Multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation System (CAIS) for the Treatment of Articular Cartilage Lesions of the Knee
Investigator Charles A. Roth, M.D.
Discipline Orthopaedics
Target Disease Cartilage Defects in the Knee

Name FIDIA
Description Multi–center, Parallel, Double–blind, Blinded Evaluator, Randomized, Placebo–controlled Study to Evaluate the Efficacy of a New Viscoelastic Hydrogel (HYMOVIS™) in the TX of Knee Osteoarthritis with an Open–label Extension
Investigator Charles A. Roth, M.D.
Discipline Orthopaedics
Target Disease  

Name IL Pharma
Description Randomized, Multi–center Double–blind, Placebo–controlled Phase III Trial to Evaluate the Efficacy,Tolerability & Safety of MRX–7EAT Etodolac–Lidocaine Topical Patch in TX of Ankle Sprains
Investigator Joshua G. Hackel, M.D.
Discipline Orthopaedics & Sports Medicine
Target Disease  

Name In–House Research
Description Prospective study to determine the incidence of simultaneous cervical neuropathies in patients who have undergone arthroscopic rotator cuff repair
Investigator Joseph Bellapianta, M.D.
Discipline Orthopaedics
Target Disease Post–surgical Rotator Cuff Repair

Name In–House Research
Description Prospective study for the incidence of phrenic nerve palsy during a posterior approach to the brachial plexus using ultrasound guidance when performing regional anesthesia prior to scheduled outpatient shoulder surgery
Investigator Gregory V. Hickman, M.D.
Discipline Anesthesia / Pre–surgical anesthesia
Target Disease Analgesia

Name ORTHOVISC
Description A comparison of Orthovisc® to corticosteroid injection in shoulder osteoarthritis: Orthovisc® randomized clinical tria
Investigator Charles A. Roth, M.D.
Discipline Orthopaedics
Target Disease Shoulder Osteoarthritis (OA)

Name Stryker Triathlon
Description The Triathlon PKR Unicondylar Knee System Outcomes Study
Investigator Brett R. Smith, M.D.
Discipline Orthopaedics
Target Disease  

Name Stryker Tritanium
Description A Prospective, Post–market, Multi–center Study of the Tritanium® Primary Acetabular Shell
Investigator Brett R. Smith, M.D.
Discipline Orthopaedics
Target Disease  

Name VIRGO
Description Variation in recovery: Role of gender on outcomes of young acute myocardial infarction (AMI) patients
Investigator Thahn Duong–Wagner, M.D.
Discipline Cardiology
Target Disease Women, aged 55 years and younger, who experience an acute heart attack

Name ZYMOGENETICS
Description A phase 4, open–label, single–group immunogenicity and safety study of re–exposure to Recothrom® (r thrombin) in surgical hemostasis
Investigator Layne R. Yonehiro, M.D.
Discipline Vascular Surgery
Target Disease Patients with prior surgical exposure to Recothrom®
 
 
 
 
 

Andrews Institute for Orthopaedics & Sports Medicine

An affiliate of Baptist Health Care, The Andrews Institute for Orthopaedics & Sports Medicine’s mission is to provide the best medical care for the musculoskeletal system through orthopaedics and sports medicine, utilizing innovative clinical and surgical technologies, and to improve patient care through research and education, emphasizing prevention.

 

1040 Gulf Breeze Pkwy • Gulf Breeze, FL 32561

 
 
Feedback